Pliant Therapeutics Inc
General ticker "PLRX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $851.0M
Pliant Therapeutics Inc does not follow the US Stock Market performance with the rate: -10.4%.
Estimated limits based on current volatility of 3.8%: low 13.10$, high 14.14$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.04$, 17.12$]
- 2024-12-30 to 2025-12-30 estimated range: [4.94$, 12.48$]
Financial Metrics affecting the PLRX estimates:
- Negative: Non-GAAP EPS, $ of -2.76 <= 0.10
- Negative: Operating profit margin, % of -99.15 <= 1.03
- Negative: Operating cash flow per share per price, % of -11.39 <= 2.35
- Positive: -3.48 < Investing cash flow per share, $ of -2.16
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
Short-term PLRX quotes
Long-term PLRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7.57MM | $9.69MM | $1.58MM |
| Operating Expenses | $105.11MM | $136.88MM | $185.72MM |
| Operating Income | $-97.53MM | $-127.20MM | $-184.15MM |
| Non-Operating Income | $0.27MM | $3.88MM | $22.81MM |
| Interest Expense | $0.00MM | $0.79MM | $1.27MM |
| R&D Expense | $77.55MM | $96.94MM | $127.80MM |
| Income(Loss) | $-97.26MM | $-123.32MM | $-161.34MM |
| Profit(Loss) | $-97.26MM | $-123.32MM | $-161.34MM |
| Stockholders Equity | $199.06MM | $313.34MM | $473.58MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $221.22MM | $350.61MM | $512.15MM |
| Operating Cash Flow | $-75.44MM | $-94.63MM | $-116.36MM |
| Capital expenditure | $1.95MM | $1.76MM | $0.92MM |
| Investing Cash Flow | $73.70MM | $-150.20MM | $-127.01MM |
| Financing Cash Flow | $2.53MM | $226.85MM | $274.40MM |
| Earnings Per Share* | $-0.50 | $-2.89 | $-2.75 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.